Literature DB >> 9834231

Interleukin-10 abrogates the inhibition of Epstein-Barr virus-induced B-cell transformation by memory T-cell responses.

M T Bejarano1, M G Masucci.   

Abstract

In vitro infection of human B lymphocytes by Epstein-Barr virus (EBV) results in their growth transformation and establishment of immortalized lymphoblastoid cell lines. The virus was found to encode a homologue of the pleiotropic cytokine interleukin-10 (IL-10), which has wide-ranging effects on the immune system. We investigated the effect of human IL-10 (hIL-10) and viral IL-10 (vIL-10) on EBV-specific immunological memory, as assessed by the inhibition of EBV-induced B-cell transformation by the autologous T cells. We found that IL-10 abrogates the inhibitory capacity of T cells. This IL-10 effect is mediated through suppression of T-cell activation-induced IL-2 and interferon-gamma production and through a direct enhancement of EBV-infected B-cell growth.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9834231

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

Review 1.  Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.

Authors:  G Niedobitek
Journal:  Mol Pathol       Date:  2000-10

2.  Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1.

Authors:  P Steigerwald-Mullen; M G Kurilla; T J Braciale
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

3.  Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo.

Authors:  Lauri L Laichalk; David A Thorley-Lawson
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 4.  Herpesvirus-bacteria synergistic interaction in periodontitis.

Authors:  Casey Chen; Pinghui Feng; Jørgen Slots
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 7.589

Review 5.  Epstein-Barr virus infection and human malignancies.

Authors:  G Niedobitek; N Meru; H J Delecluse
Journal:  Int J Exp Pathol       Date:  2001-06       Impact factor: 1.925

Review 6.  Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis.

Authors:  Fang Wei; Qing Zhu; Ling Ding; Qing Liang; Qiliang Cai
Journal:  Virol Sin       Date:  2016-09-12       Impact factor: 4.327

7.  Dithiocarbamates and viral IL-10 collaborate in the immortalization and evasion of immune response in EBV-infected human B lymphocytes.

Authors:  Richard D Irons; Anh Tuan Le
Journal:  Chem Biol Interact       Date:  2007-11-22       Impact factor: 5.192

Review 8.  Evasion of adaptive and innate immune response mechanisms by γ-herpesviruses.

Authors:  Pinghui Feng; Ashlee Moses; Klaus Früh
Journal:  Curr Opin Virol       Date:  2013-06-02       Impact factor: 7.090

9.  The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination.

Authors:  Simon Jochum; Andreas Moosmann; Stephan Lang; Wolfgang Hammerschmidt; Reinhard Zeidler
Journal:  PLoS Pathog       Date:  2012-05-17       Impact factor: 6.823

10.  Detection of EBV infection and gene expression in oral cancer from patients in Taiwan by microarray analysis.

Authors:  Ching-Yu Yen; Min-Chi Lu; Ching-Cherng Tzeng; Jia-Yan Huang; Hsueh-Wei Chang; Ruey-Shyang Chen; Shyun-Yeu Liu; Shih-Tung Liu; Biehuoy Shieh; Ching Li
Journal:  J Biomed Biotechnol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.